INS and sarcopenia: The induction of chronic inflammation, in turn, results in further development of sarcopenia, as well as the promotion of insulin resistance, thus inhibiting insulin’s anabolic signals and favoring the development of obesity; thus, a vicious cycle is established between sarcopenia, obesity, and inflammation, leading to the SO phenotype [9,30,31].